NEW YORK, June 18, 2013 /PRNewswire/ --
Belo Corp.
Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Belo Corp. ("Belo") (BLC) to Gannett Co., Inc. (GCI) in a transaction valued at $13.75 per share in cash, or approximately $1.5 billion, plus the assumption of $715 million in existing debt for an enterprise value of approximately $2.2 billion.
Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to the Belo's shareholders.
For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.
Centerline Holding Company
Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Centerline Holding Company ("Centerline") (CLNH) to Hunt Capital Partners, LLC that it or its affiliates do not already own for cash consideration of $39.89 per share.
Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to the Centerline's shareholders.
For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.
Invacare Corporation
Lifshitz Law Firm announces that a class action suit was filed in the United States District Court for the District of New Jersey, alleging that Invacare Corporation (IVC) ("Invacare") issued false and misleading statements to investors between July 22, 2010 through December 7, 2011, inclusive by failing to adequately disclose Invacare's noncompliance with Food and Drug Administration ("FDA") guidelines and Current Good Manufacturing Practices ("CGMP"), and masked the fact that Invacare suffered from widespread operational, quality, and regulatory deficiencies. Specifically, Invacare concealed from investors that it received a series of warnings from the FDA -- known as Forms 483 -- which identified serious compliance violations at its two major United States-based manufacturing facilities. The firm is investigating legal claims against the officers and Board of Directors of Invacare.
For more information, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.
StellarOne Corporation
Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of StellarOne Corporation ("StellarOne") (STEL) to Union First Market Bankshares Corporation ("Union") in a transaction with an implied a deal value per share of $19.50 or approximately $445.1 million in the aggregate based on Union's closing stock price of $20.02 on June 7, 2013.
Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to the StellarOne's shareholders.
For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.
Lifshitz Law Firm is a New York based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at www.jlclasslaw.com.
ATTORNEY ADVERTISING. © 2013 Lifshitz Law Firm. The law firm responsible for this advertisement is Lifshitz Law Firm, 18 East 41st Street, New York, New York 10017, (212) 213-6222. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law Firm
Phone: 212-213-6222
Email: info@jlclasslaw.com
SOURCE Lifshitz Law Firm